Scarica l'app Stockscreener
3.55
1.93%
-0.07
Dopo l'orario di chiusura:
3.56
0.01
+0.28%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Rocket Pharmaceuticals Inc Borsa (RCKT) Ultime notizie
Rally Mode: Is Rocket Pharmaceuticals Inc stock a good dividend stockPrice Action & Technical Confirmation Alerts - baoquankhu1.vn
US premarket movers: Argan, Rocket Pharmaceuticals, Unity - msn.com
Rocket gene therapy, among FDA’s March approvals, earns PRV - BioCentury
RCKT stock dives despite gene therapy approval — Wall Street dismisses sell-off - MSN
[SC TO-C] ROCKET PHARMACEUTICALS, INC. Tender Offer Communication | RCKT SEC FilingForm SC TO-C - Stock Titan
FDA Grants Accelerated Approval to Rocket Pharma’s Gene Therapy Kresladi for LAD-I - The Indian Practitioner
RCKTW SEC FilingsROCKET PHARMACEUTICALS INC 10-K, 10-Q, 8-K Forms - Stock Titan
Rocket Pharmaceuticals Inc (9IP1.DU) valuation measures and financial statistics - Yahoo Finance UK
Momentum Shift: What are Rocket Pharmaceuticals Incs growth levers2026 Action & Fast Entry High Yield Tips - baoquankhu1.vn
Rocket Pharmaceuticals, Inc. $RCKT Shares Acquired by JPMorgan Chase & Co. - marketbeat.com
Why Rocket Pharmaceuticals (RCKT) got a commercial boost from FDA approval of KRESLADI - msn.com
Aug Analyst Calls: Can Rocket Pharmaceuticals Inc expand into new markets2026 Market Overview & Verified Momentum Stock Alerts - baoquankhu1.vn
Rocket Pharmaceuticals Inc (9IP1.DU) Interactive Stock Chart - Yahoo! Finance Canada
RCKT: B of A Securities Raises Price Target on Buy Rating | RCKT Stock News - GuruFocus
Buyback Watch: Is Rocket Pharmaceuticals Inc Equity Warrant forming a breakout pattern2026 Setups & Accurate Technical Buy Alerts - baoquankhu1.vn
Risks Report: Is Rocket Pharmaceuticals Inc forming a bullish divergenceTrade Performance Summary & Growth-Oriented Investment Plans - baoquankhu1.vn
RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease - The Globe and Mail
Rocket Pharmaceuticals Files $400M Mixed Shelf Offering, Opens Financing Doors - timothysykes.com
Bank of America Forecasts Strong Price Appreciation for Rocket Pharmaceuticals (NASDAQ:RCKT) Stock - marketbeat.com
RCKT Shares Fall Even After FDA Approves Gene Therapy for Uncommon Disease - bitget.com
Why Rocket Pharmaceuticals (RCKT) Got a Commercial Boost From FDA Approval of KRESLADI - Insider Monkey
FDA Approval Makes Rocket Pharma Gene Therapy the First for Ultra-Rare Immune Disorder - MedCity News
Rocket Pharmaceuticals (RCKT) Is Down 8.9% After FDA Accelerated Approval Of KRESLADI Gene Therapy - Yahoo Finance
Aug Analyst Calls: Whats the beta of Rocket Pharmaceuticals Inc Equity Warrant stock2026 Sector Review & Smart Money Movement Tracker - baoquankhu1.vn
Rocket Pharmaceuticals: Kresladi Approval Validates Platform, But Commercial Upside Remains Limited - Seeking Alpha
Rocket Pharma rises as FDA approves gene therapy - MSN
Rocket Pharmaceuticals Delivers Bold Moves Amid Volatile Market - timothysykes.com
A Quick Look at Today's Ratings for Rocket Pharmaceuticals(RCKT.US), With a Forecast Between $9 to $16 - Moomoo
FDA approves Rocket Pharma’s Kresladi for severe LAD-I - thepharmaletter.com
Rocket Pharmaceuticals Faces A Make-Or-Break FDA Call On KRESLADI - finimize.com
BofA raises Rocket Pharmaceuticals price target on execution view By Investing.com - Investing.com Canada
Rocket Has Liftoff With Kresladi Approval, But Market Remains Small - insights.citeline.com
FDA approves Rocket’s Kresladi as first gene therapy for LAD-I - BioWorld MedTech
Rocket Pharmaceuticals (RCKT) Stock Pops on Historic FDA Gene Therapy Win - MEXC Exchange
Leerink raises Rocket Pharmaceuticals stock price target on FDA approval By Investing.com - Investing.com Canada
Rocket Pharmaceuticals (RCKT) Stock Surges After FDA Approves Groundbreaking Gene Therapy - MEXC
RCKT Stock Dives Despite Gene Therapy Approval — Wall Street Dismisses Sell-Off - Stocktwits
Rocket Pharmaceuticals wins FDA nod for KRESLADI gene therapy - tipranks.com
Rocket Pharmaceuticals, Argan jump premarket; Two Harbors inches down By Investing.com - Investing.com Canada
Chardan Capital Reiterates Buy Rating for Rocket Pharmaceuticals (NASDAQ:RCKT) - MarketBeat
Market movers: Unity, Rocket Pharma, Carnival Corp... - Proactive financial news
Rocket Pharma shares fall despite FDA nod for childhood disorder treatment - Reuters
Promising Biotech Stocks To Add to Your WatchlistMarch 27th - MarketBeat
Morgan Stanley reiterates Rocket Pharmaceuticals stock rating on Kresladi approval - Investing.com Canada
Vanguard Disaggregates Rocket Pharmaceuticals Holdings (NASDAQ: RCKT) - Stock Titan
Chardan reiterates Rocket Pharmaceuticals stock rating on FDA approval By Investing.com - Investing.com Canada
Chardan reiterates Rocket Pharmaceuticals stock rating on FDA approval - Investing.com
Rocket Pharma wins FDA nod for gene therapy (RCKT:NASDAQ) - Seeking Alpha
US Stocks: Rocket Pharma shares fall 15% despite FDA nod for childhood disorder treatment - The Economic Times
RCKT Faces Financial Jutsu Amid Price Target Revaluation - stockstotrade.com
Why is Rocket Pharma stock soaring Friday? - MSN
Wedbush Maintains Rocket Pharmaceuticals(RCKT.US) With Buy Rating, Maintains Target Price $16 - Moomoo
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):